1. First-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development. Issue 3 (4th March 2022) Authors: Rocco, Danilo; Della Gravara, Luigi; Battiloro, Ciro; Gridelli, Cesare Journal: Expert review of respiratory medicine Issue: Volume 16:Issue 3(2022) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples. Issue 1 (2nd October 2018) Authors: Pepe, Francesco; De Luca, Caterina; Smeraglio, Riccardo; Pisapia, Pasquale; Sgariglia, Roberta; Nacchio, Mariantonia; Russo, Maria; Serra, Nicola; Rocco, Danilo; Battiloro, Ciro; Ambrosio, Francesca; Gragnano, Gianluca; Vigliar, Elena; Bellevicine, Claudio; Troncone, Giancarlo; Malapelle, Umberto Journal: Journal of clinical pathology Issue: Volume 72:Issue 1(2019) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Recently approved and emerging monoclonal antibody immune checkpoint inhibitors for the treatment of advanced non-small cell lung cancer. (4th March 2023) Authors: Rocco, Danilo; Della Gravara, Luigi; Battiloro, Ciro; Palazzolo, Giovanni; Gridelli, Cesare Journal: Expert opinion on biological therapy Issue: Volume 23:Number 3(2023) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The role of combination chemo-immunotherapy in advanced non-small cell lung cancer. Issue 7 (3rd July 2019) Authors: Rocco, Danilo; Della Gravara, Luigi; Battiloro, Ciro; Gridelli, Cesare Journal: Expert review of anticancer therapy Issue: Volume 19:Issue 7(2019) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The role of nivolumab combined to immunotherapy and/or chemotherapy in the first-line treatment of advanced Non Small Cell Lung Cancer. (4th March 2021) Authors: Rocco, Danilo; Della Gravara, Luigi; Battiloro, Ciro; Gridelli, Cesare Journal: Expert opinion on biological therapy Issue: Volume 21:Number 3(2021) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The treatment of advanced lung adenocarcinoma with activating EGFR mutations. (12th December 2021) Authors: Rocco, Danilo; Della Gravara, Luigi; Battiloro, Ciro; Maione, Paolo; Gridelli, Cesare Journal: Expert opinion on pharmacotherapy Issue: Volume 22:Number 18(2021) Page Start: 2475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. What pharmacotherapeutics should one use for early stage non-small cell lung cancer?. (2nd September 2018) Authors: Battiloro, Ciro; Della Gravara, Luigi; Rocco, Danilo; Gridelli, Cesare Journal: Expert opinion on pharmacotherapy Issue: Volume 19:Number 13(2018) Page Start: 1403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗